Pharmafile Logo
Pharmafocus logo
Advanced Search

Zocor approved for sale over-the-counter

May 14, 2004

News

Clinicians still struggling to gain control of NHS

May 14, 2004

News

TNF-blockers continue to expand indications

May 14, 2004

Competitors in one of the industry's fastest growing markets, the TNF-blocker class of rheumatoid arthritis drugs, have gained extensions to …

News

New laws to combat animal rights extremists

May 14, 2004

New legislation will be introduced to combat animal rights extremists' violence against those involved in using animals in medical research.But …

News

Women returning to HRT

May 14, 2004

News

GSK sued for ‘abandoning’ Relenza

May 14, 2004

Biota, the Australian biotech company that discovered Relenza, is taking GlaxoSmithKline to court, alleging that it failed to properly launch …

News

Antisoma and Roche’s ovarian cancer drug disappoints

May 12, 2004

A phase III trial of a drug to treat ovarian cancer has disappointed and is likely to be dropped, co-developers …

News

UK and Ireland spoil Exanta’s European approval

May 11, 2004

News

Intervention from Paris secures French future for Aventis

May 7, 2004

Aventis has dropped its long-running opposition to a takeover bid by French compatriots Sanofi-Synthlabo after the offer to its shareholders …

News

OTC Zocor to be cleared but divisions persist

April 28, 2004

The government is shortly to announce the approval of the world's first over-the-counter statin, Zocor Heart Pro, but is unlikely …

News

Burson-Marsteller to launch cancer treatment in the UK

April 28, 2004

Burson-Marsteller, a subsidiary of the WPP advertising giant, has been appointed PR campaign handler for the UK launch of Velcade, …

News

NHS finances a cause for concern, says watchdog

April 28, 2004

News

Patients still being denied access to colon cancer treatments

April 28, 2004

A new Roche-sponsored survey of patients with bowel cancer has found that most are still not being consulted on the …

News

BMA chairman warns reforms add to threat of ‘two-tier NHS’

April 26, 2004

The chairman of the BMA has warned that new reforms are adding to the threat of a two-tier NHS posed …

News

US legal action Aventis’ latest weapon in repelling Sanofi

April 26, 2004

Aventis has unleashed its latest stratagem in resisting Sanofi-Synthleabo's hostile takeover bid, a US legal action claiming its rival has …

News

A tale of two pills for Pfizer in Q1

April 26, 2004
Pfizer, torceptrapib

 The first quarter of 2004 saw Pfizer’s biggest seller Lipitor extend its domination of the statin market but Viagra, another …

News

Aventis’ Apidra approved in US

April 26, 2004

The FDA has approved Aventis' rapid-acting insulin analogue Apidra, ahead of an anticipated August approval by the EMEA, as the …

News

No change one year on from NSF, says diabetes charity

April 26, 2004

One year on from the launch of the National Service Framework (NSF) for Diabetes, the planning of care has improved …

News

Wyeth’s Zoton hot on the heels of over-the-counter Zanprol

April 26, 2004

Wyeth, manufacturers of the UK's biggest selling prescription drug Zoton plan to take the drug POM-P, hot on the heels …

News

The brave new GMS world

April 26, 2004

The new General Medical Services contract (nGMS) started officially on 1st April, though its far-reaching effects may be far from …

Feature
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026